Lisa V. E. Oostenbrink

Therapeutic Drug Monitoring of Conditioning Agents in Pediatric Allogeneic Stem Cell Transplantation; Where do We Stand?

J. Zwaveling, R. Bredius, A. Lankester, 2022, Frontiers in Pharmacology.

Differential Elimination of Anti-Thymocyte Globulin of Fresenius and Genzyme Impacts T-Cell Reconstitution After Hematopoietic Stem Cell Transplantation

M. Schilham, R. Bredius, A. Lankester, 2019, Front. Immunol..

Successful mismatched hematopoietic stem cell transplantation for pediatric hemoglobinopathy by using ATG and post-transplant cyclophosphamide

M. Schilham, F. Smiers, R. Bredius, 2021, Bone Marrow Transplantation.

Tumor-expressed factor VII is associated with survival and regulates tumor progression in breast cancer

P. Kuppen, E. Stanganello, H. Versteeg, 2023, Blood advances.

Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16-17 may 2019, Regensburg, Germany: What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation?

M. Schilham, F. Smiers, R. Bredius, 2020, Hematology/oncology and stem cell therapy.